www.medical-devices.tech
05
'26
Written on Modified on
Agilent At SLAS2026 Conference
From February 7-11, in Boston, Agilent introduces AI-driven automation and imaging platforms to help research labs accelerate scientific discovery with efficiency and integrity.
www.agilent.com

Modern laboratories increasingly seek to overcome the limitations of closed-loop proprietary systems that restrict hardware choices and complicate data integration. Agilent has addressed this challenge by developing a next-generation automation ecosystem defined by open connectivity and cross-vendor compatibility. Unlike traditional competitors who often require laboratories to commit to a single-brand environment, Agilent’s strategy centers on a collaborative infrastructure that integrates its high-performance instrumentation with third-party robotics and software from leaders like ABB Robotics, HighRes Biosolutions, Biosero, and Unite Labs. This approach ensures that researchers can build customized, best-in-class workflows without sacrificing data integrity or operational flexibility.
Advancing High-Content Imaging and Screening Efficiency
A key differentiator in the Agilent portfolio is the continued evolution of the Cytation imaging family. The latest additions to this platform feature enhanced imaging optics and optimized data acquisition speeds, designed to surpass standard market offerings in high-content imaging. By reducing the time required for complex screening applications while maintaining superior data quality, this technology allows research and screening labs to achieve actionable insights significantly faster than with previous-generation imaging tools.
Regulatory Compliance and Data Integrity in Biopharma
In the highly regulated pharmaceutical and biopharmaceutical manufacturing sectors, compliance is often a bottleneck. Agilent’s new ProteoAnalyzer Software Security Module provides a competitive edge by streamlining the path to global regulatory adherence, including 21 CFR Part 11 and Annex 11. The module integrates secure user authentication, electronic signatures, and comprehensive audit trails directly into the workflow. This built-in security reduces the administrative burden on lab managers and minimizes the risk of compliance-related delays, a common pain point when using less integrated software solutions.
AI-Driven Productivity and Predictive Maintenance
Operational downtime remains one of the most significant costs in laboratory management. Agilent differentiates its service offering through the integration of Sigsense intelligent monitoring technology within the CrossLab Connect platform. This AI-powered tool provides real-time performance analytics and predictive alerts, allowing laboratories to move beyond reactive maintenance. By utilizing asset-utilization insights to optimize instrument uptime, Agilent’s ecosystem helps laboratories maximize their return on investment and maintain consistent productivity in a way that static, non-connected systems cannot match.
Optimized Workflows for Emerging Therapeutics
The versatility of the Agilent ecosystem is further demonstrated through specialized automation protocols, such as the newly developed Bravo liquid-handling sequences for GLP-1 agonist sample preparation. By providing validated, automation-ready protocols for high-demand research areas, Agilent ensures that its users can pivot quickly to emerging scientific trends. This combination of specialized application support and a flexible hardware-software framework establishes a new standard for the automated laboratory of the future.
www.agilent.com

